A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model
Clinical trial NCT06170242 · COMPLETED
Trial details
- NCT number
- NCT06170242
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-20
- Primary completion
- 2024-06-17
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.